Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Despite advances in reducing HIV-related mortality, persistently high HIV incidence rates are undermining global efforts to end the epidemic by 2030. The UNAIDS Fast-track targets as well as other preventative strategies, such as pre-exposure prophylaxis, have been identified as priority areas to reduce the ongoing transmission threatening to undermine recent progress. Accurate and granular risk prediction is critical for these campaigns but is often lacking in regions where the burden is highest. Owing to their ability to capture complex interactions between data, machine learning and artificial intelligence algorithms have proven effective at predicting the risk of HIV infection in both high resource and low resource settings. However, interpretability of these algorithms presents a challenge to the understanding and adoption of these algorithms. In this perspectives article, we provide an introduction to machine learning and discuss some of the important considerations when choosing the variables used in model development and when evaluating the performance of different machine learning algorithms, as well as the role emerging tools such as Shapely Additive Explanations may play in helping understand and decompose these models in the context of HIV. Finally, we discuss some of the potential public health and clinical use cases for such decomposed risk assessment models in directing testing and preventative interventions including pre-exposure prophylaxis, as well as highlight the potential integration synergies with algorithms that predict the risk of sexually transmitted infections and tuberculosis.

Original publication

DOI

10.3389/frph.2022.1062387

Type

Journal

Frontiers in Reproductive Health

Publisher

Frontiers Media SA

Publication Date

22/12/2022

Volume

4